In vitro activity of clarithromycin (TE-031, A-67268) and 14OH-clarithromycin alone and in combination againstLegionella species
- 1 November 1990
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 9 (11) , 846-848
- https://doi.org/10.1007/bf01967390
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humansAntimicrobial Agents and Chemotherapy, 1990
- Antimicrobial activity and interaction of pefloxacin and its principal metabolitesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- A review of cephalosporin metabolism: A lesson to be learned for future chemotherapyDiagnostic Microbiology and Infectious Disease, 1989
- Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- The antimicrobial activity of A-56268 (TE-031) and roxithromycin (RU965) against Legionella using broth microdilution methodJournal of Antimicrobial Chemotherapy, 1987
- The Effect of charcoal on MICs for LegionellaJournal of Antimicrobial Chemotherapy, 1986
- Detennlnation of the activity onLegionella of eight macrolides and related agents by comparative testing on three mediaJournal of Antimicrobial Chemotherapy, 1985
- Tolerance ofLegionella species to sodium chlorideCurrent Microbiology, 1983